The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Regeneron Pharmaceuticals Inc

Nasdaq: REGN
Last

(U.S.) $439.40

Today's change-12.08 -2.68%
Updated April 1 9:47 AM EDT. Delayed by at least 15 minutes.
 

Regeneron Pharmaceuticals Inc

Nasdaq: REGN
Last

(U.S.) $439.40

Today's change-12.08 -2.68%
Updated April 1 9:47 AM EDT. Delayed by at least 15 minutes.

Regeneron Pharmaceuticals Inc crosses below 20-day moving average

Regeneron Pharmaceuticals Inc is sharply lower today, dropping (U.S.)$12.08 or 2.68% to (U.S.)$439.40 and crossing below its 20-day moving average. Shares have lost 3.21% over the last five days, but have gained 7.11% over the last year to date. This security has outperformed the S&P 500 by 34.26% during the last year.

Key company metrics

  • Open(U.S.) $450.00
  • Previous close(U.S.) $451.48
  • High(U.S.) $450.00
  • Low(U.S.) $439.20
  • Bid / Ask(U.S.) $439.20 / (U.S.) $440.28
  • YTD % change+7.11%
  • Volume100,997
  • Average volume (10-day)1,063,292
  • Average volume (1-month)957,274
  • Average volume (3-month)894,715
  • 52-week range(U.S.) $269.50 to (U.S.) $495.50
  • Beta0.86
  • Trailing P/E143.00×
  • P/E 1 year forward41.42×
  • Forward PEG2.20×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.07
Updated April 1 9:47 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.34%

Based on its net profit margin of 12.34%, Regeneron Pharmaceuticals Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.06%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue802726666626
Total other revenue--------
Total revenue802726666626
Gross profit743670619582
Total cost of revenue59564644
Total operating expense578543454440
Selling / general / administrative144150102109
Research & development352338295287
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)23011--
Other operating expenses, total--------
Operating income225183212186
Interest income (expense), net non-operating-6-9-10-12
Gain (loss) on sale of assets--------
Other--------
Income before tax221176203175
Income after tax110809365
Income tax, total11196110110
Net income110809365
Total adjustments to net income--------
Net income before extra. items110809365
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items110809365
Inc. avail. to common incl. extra. items110809365
Diluted net income110839365
Dilution adjustment0300
Diluted weighted average shares114117113112
Diluted EPS excluding extraordinary itemsvalue per share0.970.700.820.58
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.070.700.860.58